OWC Pharmaceutical Research Corp (OWCP)

[skitahoe]

Bruce,

I don't believe you're correct, but I do believe that expectations may have been higher then the reality of what could be presented there. I believe it's clear that the psoriasis and other meds are working well in trials, but trial results normally are presented for peer review before they're discussed in any detail. I believe the company created optimism about what's expected, but is waiting to get specific for when the time is right.

Judging by what others have said, the conference in Israel beginning March 20th may be precisely the right place to present the data. I'm uncertain that in the cannabis world that their are conferences like ASCO, AACR, etc. but this conference may be the closest thing.

The company has led that more information would be available in the next few weeks, March 20th falls right in line with what they've said. I believe that recent stock movement presents what may be the last great buying opportunity. If the company not only lives up to expectations on the data, but also actually has approval to sell the product by mid year, even if it's only in Israel, the $1 to $2 billion market cap that people discuss here is certainly possible. That's a stock price from about $7 to $15.

Gary